Skip to main content

Table 5 Laboratory data of the study subjects post-IVIG treatment

From: Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease

Parameter

repeated IVIG-responsive group

(n = 54)

repeated IVIG-resistant group

(n = 40)

p

WBC count (×10 9 /L)

14.26(12.93 ~ 15.66)

14.03(9.96 ~ 16.19)

0.125

 N%

62.50(59.50 ~ 75.60)

74.40(64.77 ~ 78.95)

0.008*

Hb (g/L)

105(93 ~ 116)

96(85 ~ 107)

0.004*

PLT (×10 9 /L)

370(295 ~ 461)

354(280 ~ 429)

0.253

CRP (mg/L)

41.0(27.3 ~ 65.8)

76.0(50.0 ~ 124.0)

< 0.001*

ALT (U/L)

46.4(14.6 ~ 138.6)

56.0(23.0 ~ 122.4)

0.763

AST (U/L)

57.1(28.7 ~ 123.9)

33.0(25.1 ~ 89.7)

0.081

ALB (g/L)

31.2(28.6 ~ 33.1)

29.4(27.6 ~ 31.5)

0.010*

  1. *Statistically significant (P < 0.05)
  2. WBC white blood cell, N%: percentage of neutrophils, Hb hemoglobin, PLT platelet, CRP C-reactive protein, ALT alanine aminotransferase, AST aspartate transaminase, ALB albumin